Motley Fool
BlackBarn Capital Builds Warby Parker Stake as the Direct-to-Consumer Eyewear Leader Expands Nationwide
📊
AI Sentiment
Positive
6/10
Roivant Sciences Ltd. News
Latest updates and market news for ROIV
13 news
Feb 28 - Mar 6, 2026
Page 1
Investor's Business Daily
Moderna Stock Pops After Inking $950 Million Covid Vaccine Settlement
📈
AI Sentiment
Highly Positive
8/10
Simply Wall St.
A Look At Roivant Sciences (ROIV) Valuation After Recent Share Price Strength
📈
AI Sentiment
Highly Positive
8/10
The Wall Street Journal
Stocks to Watch Wednesday: Coinbase, CrowdStrike, Gitlab, Moderna
📉
AI Sentiment
Negative
2/10
Investor's Business Daily
Moderna Pops After Inking $950 Million Covid Vaccine Settlement
24/7 Wall St.
Moderna and Ross Stores Lead Stock Gainers on Wednesday
📈
AI Sentiment
Highly Positive
9/10
Simply Wall St.
What Roivant Sciences (ROIV)'s Priority FDA Review for Brepocitinib in Dermatomyositis Means For Shareholders
📊
AI Sentiment
Positive
7/10
GlobeNewswire
Genevant Sciences and Arbutus Biopharma Announce $2.25 Billion Global Settlement With Moderna
📈
AI Sentiment
Highly Positive
10/10
MT Newswires
Roivant's Priovant Says FDA Accepts Application With Priority Review for Dermatomyositis Treatment
âž–
AI Sentiment
Neutral
5/10
GlobeNewswire
Priovant Announces FDA Acceptance and Priority Review of New Drug Application for Brepocitinib in Dermatomyositis
📈
AI Sentiment
Highly Positive
9/10
Share this news page